Download Free Sample Report

The global Hospital Infection Therapeutics market was valued at US$ 2803.3 million in 2022 and is projected to reach US$ 3303.6 million by 2029, at a CAGR of 2.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
This report aims to provide a comprehensive presentation of the global market for Hospital Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Infection Therapeutics. This report contains market size and forecasts of Hospital Infection Therapeutics in global, including the following market information:

• Global Hospital Infection Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
• Global top five companies in 2022 (%)

The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Infection Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Infection Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Hospital Infection Therapeutics Market Segment Percentages, by Type, 2022 (%)

• Antibacterial Drugs
• Antiviral Drugs
• Antifungal Drugs

Global Hospital Infection Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Hospital Infection Therapeutics Market Segment Percentages, by Application, 2022 (%)

• Hospital Acquired Pneumonia
• Surgical Site Infections
• Urinary Tract Infection
• Gastrointestinal Disorders
• Bloodstream Infections
• Others

Global Hospital Infection Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Hospital Infection Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Infection Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital Infection Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• Johnson & Johnson Services
• Actavis
• Sanofi
• Bristol Myers Squibb Company
• AstraZeneca
• Pfizer
• Merck
• GlaxoSmithkline
• Cubist Pharmaceuticals

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Hospital Infection Therapeutics, market overview.
• Chapter 2: Global Hospital Infection Therapeutics market size in revenue.
• Chapter 3: Detailed analysis of Hospital Infection Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Hospital Infection Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.